http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011128407-A9
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce3db4abf2befac6eb935455b12959e6 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate | 2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_097a1e7f99844da49884516bea08e044 |
publicationDate | 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2011128407-A9 |
titleOfInvention | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations |
abstract | The present invention relates to : * combinations of : component A : one or more 2,3-dihydroimidazo[1,2-c]quinazoline compounds of general formula (A1) or (A2), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; component B : one or more N-(2-arylamino) aryl sulfonamide compounds of general formula (B), or Lapatinib, or Paclitaxel, or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; and, optionally, component C : one or more further pharmaceutical agents; in which optionally some or all of the components are in the form of a pharmaceutical formulation which is ready for use to be administered simultaneously, concurrently, separately or sequentially. dependently of one another by the oral, intravenous, topical, local installations, intraperitoneal or nasal route; * use of such combinations for the preparation of a medicament for the treatment or prophylaxis of a cancer; and * a kit comprising such a combination. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108884098-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185549-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108884098-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844066-B2 |
priorityDate | 2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1803.